Emcure Pharmaceuticals Limited has made a regulatory disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure concerns the availability of the audio recording for the company's Q1 FY27 earnings call.
The earnings call was held on August 06, 2026, as previously intimated to the exchanges on July 15, 2026. The audio recording of this call is now available on the company's official website. The specific URL provided for access is: https://www.emcure.com/wp-content/uploads/2026/08/Audio-Q1FY27.mp3.
The disclosure was signed by Amruta Amit Yangalwar, Company Secretary & Compliance Officer (ICSI Membership No.: A25687), on behalf of Emcure Pharmaceuticals Limited. The document reference number is EPL/CS/SE/0069/2026.
Financial Impact
No specific financial figures, operational metrics, or guidance from the earnings call are disclosed in this filing. The document solely announces the availability of the recording.